Review greenlights systemic psoriasis therapies for over 65s

But there is a critical need for more evidence in this population, the authors say

Age alone should not limit use of systemic therapies in people aged over 65 with psoriasis, the authors of a systematic review say.

senior man with psoriasis on abdomen and arm

The Dutch researchers aimed to pull together the evidence for both conventional and biologic therapies for psoriasis in this age group, examining 31 studies including a total of almost 40,000 patients.

Overall, only limited data was available for specific agents and the quality of evidence was low for conventional therapies, they